321P Results of an open-label, single-arm phase II trial investigating the efficacy and safety of trifluridine/tipiracil combined with irinotecan as a second-line therapy in patients with cholangiocarcinoma (TRITICC). - Roderburg, C.; Gonzalez Carmona, M.A.; Berres, M-L.; Modest, D.P.; Mohr, R.; Wree, A.; Venerito, M.; Keitel, V.; Waldschmidt, D.T.; Lüdde, T.; Kehmann, L. (Annals of Oncology, 2025)